Status:
WITHDRAWN
Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)
Lead Sponsor:
Stanford University
Conditions:
Primary Knee Replacement Surgery
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study involves an exoskeleton which is believed to increase quadriceps muscle strength in the rehabilitation phase after TKA and reduce the discharge the such patients in Extended care facility (...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients undergoing unilateral primary knee replacement surgery
- Patients who pre-operatively desire discharged to ECF
- Patients willing and capable to sign the written informed consent
- Exclusion criteria
- Patients undergoing bilateral primary knee replacement surgery
- Patients undergoing revision knee replacement surgery
- Patients who pre-operatively desire discharged to Home
- Patients not willing and capable to sign the written informed consent
Exclusion
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03762603
Start Date
September 1 2025
End Date
December 20 2027
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Palo Alto, California, United States, 94063